Patient-Controlled Analgesia Proves Safe in Children

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

SEATTLE--In a retrospective study of 39 children (aged 4 to 12 years) given patient-controlled analgesia (PCA) for pain associated with bone marrow transplantation (BMT), researchers found that 95% of children successfully mastered PCA to control their pain.

SEATTLE--In a retrospective study of 39 children (aged 4 to 12years) given patient-controlled analgesia (PCA) for pain associatedwith bone marrow transplantation (BMT), researchers found that95% of children successfully mastered PCA to control their pain.

"We observed no instances of drug misuse, parental tampering,accidental overdose, or difficulty weaning from opioids,"said Peter J. Dunbar, MB, ChB, and his colleagues at the FredHutchinson Cancer Research Center and the University of WashingtonSchool of Medicine.

The research team concluded that opioid PCA, with or without continuousinfusion, over several days or weeks is safe and effective forpreteen children with BMT-related pain (J Pain Symptom Manage10:604-611, 1995).

Recent Videos
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content